Denali Growth Partners

What Denali Growth Partners does

Denali Growth Partners (legal entity Dinale Management, LLC) is a Boston-based growth equity firm founded in 2021 by Jesse Lane, the former growth equity investor at Summit Partners, alongside co-founder and Managing Director Breanna McKeehan. The firm invests in entrepreneurial and founder-led businesses across three horizontal verticals — healthcare and life sciences, software and technology, and tech-enabled business services — offering both minority and majority structures alongside operational support, board involvement, and access to a network of 30+ healthcare and technology executives. Disclosed portfolio activity spans NationsBenefits, Sollis Health, Boston Veterinary Clinic, HiLabs, Tobin Scientific, Slipstream, MD Integrations, and BEESY, with check sizes ranging from minority co-investments to lead positions such as the $65M Tobin Scientific round.

The firm closed its inaugural fund of approximately $203M in April 2021 and raised a $400M second fund in May 2025, bringing Regulatory Assets Under Management to $750M+ as of January 2026. Revenue mechanics follow the standard private fund model — recurring management fees on committed/invested AUM plus performance-based carried interest on realizations — and are not publicly disclosed. Distribution is direct: the firm sources and executes investments through founder and CEO relationships rather than intermediaries, supported by a lean team of roughly 13 named professionals across investment, portfolio operations, and fund finance functions.

Denali's value proposition is positioned as "more than capital," emphasizing operational partnership, sector-specific executive mentorship, and customized support structures over pure financial returns. The firm has been recognized with the 2023 Private Equity Wire US Emerging Managers Award for Best Performance in Growth Equity and the 2023 Private Equity & Venture Capital Award for Best HealthTech Growth Equity Firm, and it operates exclusively from its 545 Boylston Street, Suite 1101 headquarters in Boston, Massachusetts.

Name

Denali Growth Partners

Legal name

Dinale Management, LLC

Website

https://denaligrowth.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Denali Growth Partners is a Boston-based growth equity firm founded in 2021 that invests minority and majority capital in founder-led healthcare, technology, and tech-enabled services companies, pairing funding with operational support and an executive mentorship network.

Ownership category

akta.pro rank

Product category

Growth Equity / Private Equity

NAICS

All Other Financial Investment Activities (52399), Miscellaneous Financial Investment Activities (523999)

SIC

Investors, Nec (6799)

akta.pro primary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

akta.pro secondary industries

Healthcare & Life Sciences Growth Equity (FSANACAB), Technology & Software Growth Equity (FSANACAA)

Keywords

• Growth equity investment
• Private equity firm
• Healthcare growth investing
• Venture capital funding
• Portfolio management services

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Core offering

Denali Growth Partners is a Boston-based growth equity investment firm that deploys capital from dedicated funds into growth-stage companies in healthcare, technology, and tech-enabled business services. The firm provides both minority and majority equity investments paired with operational support, executive mentorship, and access to a network of 30+ healthcare and technology executives, targeting driven, founder-led businesses seeking more than capital. The firm manages over $750M in regulatory assets under management and has invested in companies such as NationsBenefits, Sollis Health, HiLabs, Tobin Scientific, MD Integrations, and BEESY.

Product overview

Denali Growth Partners (DGP) is a growth equity investment firm, not a product-based technology company. As an investment firm, DGP does not offer software products, platforms, or technology services. The firm's business model involves providing capital and operational support to portfolio companies in healthcare, technology, and tech-enabled services sectors. DGP partners with exceptional founders and growth-stage companies, offering both minority and majority investment structures, without developing or selling its own products or services.

Differentiator

Problem solved

Functional benefit

Products and services

• Denali Growth Equity Fund I (Inaugural Fund) The firm's inaugural growth equity fund vehicle, providing committed capital for minority and majority investments in growth-stage healthcare, technology, and tech-enabled services companies. Closed in April 2021 at approximately $203M and used to deploy investments such as NationsBenefits, Sollis Health, and HiLabs. Available to founders and management teams seeking growth capital partnered with operational support.
• Denali Growth Equity Fund II The firm's second growth equity fund vehicle, with $400M in commitments closed in May 2025, providing capital for continued growth equity investments in healthcare, technology, and services companies. Used to deploy investments such as Tobin Scientific, Slipstream, MD Integrations, and BEESY. Available to founders and management teams seeking growth capital and operational partnership.
• Portfolio Operations Support Operational and strategic support service provided to portfolio companies alongside capital deployment, leveraging the firm's network of 30+ healthcare and technology executives and an internal Portfolio Operations team led by the VP of Portfolio Operations. Includes customized strategic guidance, executive mentorship, and best-practice sharing to help portfolio companies scale. Available to founders and management teams of Denali's portfolio companies.

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Updata Partners: Growth equity firm that co-invested with Denali in MD Integrations' $77M round. Direct comparable — invests in lower middle-market software and tech-enabled services with both minority and majority structures, closely mirroring Denali's strategy and check size.
• Enhanced Healthcare Partners: Healthcare-focused growth equity firm where Denali Principal Dave Prendergast previously worked. Direct comparable — growth equity investments across healthcare IT and services with similar check sizes and founder-support orientation.
• Waud Capital Partners: Healthcare and tech-enabled services growth equity firm where Denali's Dave Prendergast held an investment role. Direct comparable — middle-market growth equity with thematic healthcare/services focus and operating partner model.
• Great Point Partners: Healthcare-focused growth equity firm in Dave Prendergast's prior background. Direct comparable — growth equity in healthcare services and life sciences, similar founder-led orientation and check sizes to Denali.
• GreyLion Partners: Co-invested with Denali in Slipstream. Direct comparable — emerging growth equity firm with comparable fund size, sector breadth, and co-investor activity in the lower middle market.
• Truck 9 Partners: Co-led the $65M Tobin Scientific round alongside Denali. Direct comparable — sector-focused growth equity firm co-investing in life sciences infrastructure at similar check sizes.

Broad incumbents

• Summit Partners: Large-scale growth equity firm where founder Jesse Lane previously worked. Comparable on strategy and sector (healthcare, technology, life sciences) but operates with substantially larger AUM and broader geographic reach.
• General Atlantic: Led the NationsBenefits follow-on round, an existing Denali portfolio company. Broad incumbent — global growth equity with healthcare and tech focus, materially larger AUM than Denali.
• Battery Ventures: Where Denali Associate Ali Mobtaker previously worked. Broad incumbent — technology-focused venture and growth equity with software/services orientation that overlaps Denali's tech-enabled services thesis.

Others

• Monroe Capital: Co-invested with Denali in NationsBenefits' $170M round. Adjacent capital provider — direct lending and private credit firm that participates alongside growth equity in healthcare and services financings.

Market position

Weaknesses1 record

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Denali Growth Partners